UnitedHealth Group Incorporated [UNH] is 6.20% higher this YTD. Is it still time to buy?

UnitedHealth Group Incorporated [NYSE: UNH] price surged by 1.09 percent to reach at $3.38. The company report on August 20, 2020 that Morehouse School of Medicine and UnitedHealth Group Collaborate to Help Expand COVID-19 Research and Health Equity for Individuals with Sickle Cell.

Study will assess COVID-19 risk and severity among individuals with sickle cell trait.

Morehouse School of Medicine (MSM) and UnitedHealth Group (NYSE: UNH) have joined forces to determine if people with sickle cell trait are at greater risk of contracting COVID-19 and if the trait results in more severe cases of the disease.

A sum of 1874964 shares traded at recent session while its average daily volume was at 3.28M shares. UnitedHealth Group Incorporated shares reached a high of $312.36 and dropped to a low of $307.80 until finishing in the latest session at $312.22.

The one-year UNH stock forecast points to a potential upside of 5.95. The average equity rating for UNH stock is currently 1.80, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on UnitedHealth Group Incorporated [UNH]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for UNH shares is $331.96 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on UNH stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

SVB Leerink have made an estimate for UnitedHealth Group Incorporated shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 01, 2020. While these analysts kept the previous recommendation, Goldman raised their target price to Buy. The new note on the price target was released on June 05, 2020, representing the official price target for UnitedHealth Group Incorporated stock. Previously, the target price had yet another raise to $308, while Deutsche Bank analysts kept a Buy rating on UNH stock.

The Average True Range (ATR) for UnitedHealth Group Incorporated is set at 6.05, with the Price to Sales ratio for UNH stock in the period of the last 12 months amounting to 1.19. The Price to Book ratio for the last quarter was 4.66, with the Price to Cash per share for the same quarter was set at 23.55. Price to Free Cash Flow for UNH in the course of the last twelve months was 18.47.

UNH Stock Performance Analysis:

UnitedHealth Group Incorporated [UNH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.45. With this latest performance, UNH shares gained by 4.56% in over the last four-week period, additionally plugging by 18.71% over the last 6 months – not to mention a rise of 35.11% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for UNH stock in for the last two-week period is set at 53.12, with the RSI for the last a single of trading hit 47.75, and the three-weeks RSI is set at 53.13 for UnitedHealth Group Incorporated [UNH]. The present Moving Average for the last 50 days of trading for this stock 304.10, while it was recorded at 312.79 for the last single week of trading, and 285.93 for the last 200 days.

Insight into UnitedHealth Group Incorporated Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and UnitedHealth Group Incorporated [UNH] shares currently have an operating margin of +8.13. UnitedHealth Group Incorporated’s Net Margin is presently recorded at +5.71.

Return on Total Capital for UNH is now 20.09, given the latest momentum, and Return on Invested Capital for the company is 15.32. Return on Equity for this stock inclined to 25.32, with Return on Assets sitting at 8.36. When it comes to the capital structure of this company, UnitedHealth Group Incorporated [UNH] has a Total Debt to Total Equity ratio set at 70.60. Additionally, UNH Total Debt to Total Capital is recorded at 41.38, with Total Debt to Total Assets ending up at 25.25. Long-Term Debt to Equity for the company is recorded at 63.89, with the Long-Term Debt to Total Capital now at 37.45.

Reflecting on the efficiency of the workforce at the company, UnitedHealth Group Incorporated [UNH] managed to generate an average of $42,582 per employee.

UNH Stock EPS

With the latest financial reports released by the company, UnitedHealth Group Incorporated posted 3.88/share EPS, while the average EPS was predicted by analysts to be reported at 3.75/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 3.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for UNH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for UnitedHealth Group Incorporated go to 12.72%.

UnitedHealth Group Incorporated [UNH] Insider Position Details

There are presently around $260,810 million, or 89.40% of UNH stock, in the hands of institutional investors. The top three institutional holders of UNH stocks are: VANGUARD GROUP INC with ownership of 80,727,140, which is approximately 7.532% of the company’s market cap and around 0.30% of the total institutional ownership; BLACKROCK INC., holding 73,347,462 shares of the stock with an approximate value of $22.9 billion in UNH stocks shares; and FMR LLC, currently with $17.25 billion in UNH stock with ownership of nearly -0.055% of the company’s market capitalization.

Positions in UnitedHealth Group Incorporated stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 1,124 institutional holders increased their position in UnitedHealth Group Incorporated [NYSE:UNH] by around 36,099,448 shares. Additionally, 953 investors decreased positions by around 36,140,880 shares, while 236 investors held positions by with 763,100,509 shares. The mentioned changes placed institutional holdings at 835,340,837 shares, according to the latest SEC report filing. UNH stock had 187 new institutional investments in for a total of 2,403,930 shares, while 91 institutional investors sold positions of 1,443,194 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam